4//SEC Filing
Cavalier Jason 4
Accession 0000950170-25-095681
CIK 0001327273other
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 9:27 PM ET
Size
5.1 KB
Accession
0000950170-25-095681
Insider Transaction Report
Form 4
Cavalier Jason
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-07-10$8.91/sh−684$6,094→ 519,316 total
Footnotes (1)
- [F1]Shares were sold to cover taxes upon the vesting of restricted stock units ("RSUs") pursuant to a mandatory Rule 10b5-1 trading instruction in the award agreement adopted by the Reporting Person on January 1, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Documents
Issuer
Lyra Therapeutics, Inc.
CIK 0001327273
Entity typeother
Related Parties
1- filerCIK 0001883290
Filing Metadata
- Form type
- 4
- Filed
- Jul 13, 8:00 PM ET
- Accepted
- Jul 14, 9:27 PM ET
- Size
- 5.1 KB